Spienic small B-cell lymphoma with IGH/BCL3 translocation

被引:22
作者
Soma, LA
Gollin, SM
Remstein, ED
Ketterling, RP
Flynn, HC
Rajasenan, KK
Swerdlow, SH [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Div Hematopathol, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh Cytogenet Lab, Pittsburgh, PA 15261 USA
[3] Univ Pittsburgh, Med Ctr, Magee Womens Hosp, Pittsburgh, PA 15213 USA
[4] Mayo Med Ctr, Div Anat Pathol, Rochester, MN 55905 USA
[5] Mayo Med Ctr, Div Hematopathol, Rochester, MN 55905 USA
[6] Mayo Med Ctr, Div Lab Genet, Rochester, MN 55905 USA
[7] UPMC, Canc Ctr Wexford, Pittsburgh, PA 15090 USA
关键词
BCL3; splenic lymphoma; fluorescence in situ hybridization; cytogenetics; B cells;
D O I
10.1016/j.humpath.2005.09.025
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Isolated chromosomal translocations are important defining features of many non-Hodgkin lymphomas, especially of B-cell type. In contrast to some other translocations, the significance of IGH/BCL3 translocations is not well defined. Although often considered a feature of the ill-defined entity atypical chronic lymphocytic leukemia, very few cases are reported in which involvement of BCL3 and the precise B-cell neoplasm are both well documented. For this reason, we report a splenic-based CD5(-), CD10(-), CD43(-), CD23(-), CD103(-), FMC7(+), CD25(+) small B-cell lymphoma associated with epithelioid histiocyte clusters and a t(14;19)(q32;q13) representing an IGH/BCL3 translocation based on classical cytogenetic studies, chromosomal painting, and fluorescence in situ hybridization studies. The previously reported neoplasms with t(14;19)(q32;q13) or IGH/BCL3 translocations are also reviewed. The present case did not fall into any of the classic B-cell lymphoma categories and clearly did not represent chronic lymphocytic leukemia/small lymphocytic lymphoma. This case suggests that the IGH/BCL3 translocation may help to define a new clinicopathologic entity. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:218 / 230
页数:13
相关论文
共 58 条
[1]  
ANASTASI J, 1992, BLOOD, V79, P1796
[2]   A narrow deletion of 7q is common to HCL, and SMZL, but not CLL [J].
Andersen, CL ;
Gruszka-Westwood, A ;
Ostergaard, M ;
Koch, J ;
Jacobsen, E ;
Kjeldsen, E ;
Nielsen, B .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 72 (06) :390-402
[3]  
ASOU H, 1993, BRIT J HAEMATOL, V85, P492
[4]   Bcl-3/IgH translocation (14;19)(q32;q13) in non-Hodgkin's lymphomas [J].
Au, WY ;
Horsman, DE ;
Ohno, H ;
Klasa, RJ ;
Gascoyne, RD .
LEUKEMIA & LYMPHOMA, 2002, 43 (04) :813-816
[5]  
BIRD ML, 1989, LEUKEMIA, V3, P182
[6]  
BLOOMFIELD CD, 1983, CANCER RES, V43, P2975
[7]   Lymph node histology in typical and atypical chronic lymphocytic leukemia [J].
Bonato, M ;
Pittaluga, S ;
Tierens, A ;
Criel, A ;
Verhoef, G ;
Wlodarska, I ;
Vanutysel, L ;
Michaux, L ;
Vandekerckhove, P ;
Van den Berghe, H ;
De Wolf-Peeters, C .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (01) :49-56
[8]   Splenic marginal zone lymphomas presenting with splenomegaly and typical immunophenotype are characterized by allelic loss in 7q31-32 [J].
Boonstra, R ;
Bosga-Bouwer, A ;
van Imhoff, GW ;
Krause, V ;
Palmer, M ;
Coupland, RW ;
Dabbagh, L ;
van den Berg, E ;
van den Berg, A ;
Poppema, S .
MODERN PATHOLOGY, 2003, 16 (12) :1210-1217
[9]  
BRAYLAN RC, 1977, CANCER, V39, P1146, DOI 10.1002/1097-0142(197703)39:3<1146::AID-CNCR2820390320>3.0.CO
[10]  
2-X